Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01872975 · ClinicalTrials.gov registry record · NA
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
A NA study of Stage II Breast Cancer and Stage IB Breast Cancer, sponsored by NSABP Foundation.
- Active
- Registry status
- NA
- Development phase
- 1,636
- Enrollment target
- 20
- Study locations
NCT01872975: Active NA study of Stage II Breast Cancer and Stage IB Breast Cancer, sponsored by NSABP Foundation.
NCT01872975 is a NA study of Stage II Breast Cancer and Stage IB Breast Cancer that is active but no longer recruiting, run by NSABP Foundation. The registered enrollment target is 1,636 participants, above the 265-participant average among 30 other Stage II Breast Cancer trials with a reported enrollment target (517% higher). The trial reports 20 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01872975, a NA study of Stage II Breast Cancer and Stage IB Breast Cancer, is active but no longer recruiting, sponsored by NSABP Foundation.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,636 participants
- Enrollment target
- 20
- Study locations
Study Summary
This randomized phase III trial studies standard or comprehensive radiation therapy in treating patients with early-stage breast cancer who have undergone surgery. Radiation therapy uses high-energy x rays to kill tumor cells. It is not yet known whether comprehensive radiation therapy is more effective than standard radiation therapy in treating patients with breast cancer
Conditions Studied
Interventions
- RADIATION regional nodal XRT
- RADIATION chestwall XRT
- RADIATION WBI
Study Locations (20)
California
- Sutter Cancer Centers Radiation Oncology Services-Auburn - Auburn
- Mills - Peninsula Hospitals - Burlingame
- Sutter Cancer Centers Radiation Oncology Services-Cameron Park - Cameron Park
- Eden Hospital Medical Center - Castro Valley
- City of Hope Comprehensive Cancer Center - Duarte
- Epic Care-Dublin - Dublin
- Epic Care Partners in Cancer Care - Emeryville
- California Cancer Center - North Fresno - Fresno
- UC San Diego Moores Cancer Center - La Jolla
Arizona
- Arizona Breast Cancer Specialists-Gilbert - Gilbert
- Arizona Center for Cancer Care-Peoria - Peoria
- Arizona Breast Cancer Specialists-Phoenix - Phoenix
- Arizona Breast Cancer Specialists-Scottsdale - Scottsdale
- Arizona Center for Cancer Care-Surprise - Surprise
- Arizona Oncology Associates-West Orange Grove - Tucson
- The University of Arizona Medical Center-University Campus - Tucson
Alabama
- University of Alabama at Birmingham Cancer Center - Birmingham
- University of South Alabama Mitchell Cancer Institute - Mobile
Alaska
- Providence Alaska Medical Center - Anchorage
Arkansas
- University of Arkansas for Medical Sciences - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,636 participants |
| Start Date | 2013-08 |
| Est. Completion | 2028-08 |
| Phase | NA |
What the registry record for NCT01872975 still lists
NCT01872975 is an interventional study that assigns participants to a tested intervention. Its 1,636 participants enrollment target places it among the larger protocols in the corpus, above the 265-participant average among 30 other Stage II Breast Cancer trials with a reported enrollment target (517% higher).
The record links to 2 conditions, with Stage II Breast Cancer appearing as the primary indexed condition, and to 3 interventions - of which regional nodal XRT is the first listed.
NCT01872975 names 20 study sites across 5 states, led by California, Arizona, Alabama.
Frequently Asked Questions
What is clinical trial NCT01872975 about?
NCT01872975 is a clinical study titled "Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery". This randomized phase III trial studies standard or comprehensive radiation therapy in treating patients with early-stage breast cancer who have undergone surgery. Radiation therapy uses high-energy x rays to kill tumor cells. It is not yet known whether comprehensive radiation therapy is more effec...
What is the current status of trial NCT01872975?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,636 participants. The study started on 2013-08. Estimated completion is 2028-08.
What conditions does trial NCT01872975 study?
This clinical trial studies the following conditions: Stage II Breast Cancer, Stage IB Breast Cancer.
What interventions are being tested in trial NCT01872975?
The interventions under investigation include: regional nodal XRT (RADIATION), chestwall XRT (RADIATION), WBI (RADIATION).
Who is sponsoring clinical trial NCT01872975?
This trial is sponsored by NSABP Foundation, which has 44 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01872975 being conducted?
This trial has 20 study locations across Alabama, Alaska, Arizona, Arkansas, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stage II Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01872975's enrollment target sits among peer trials
1,636 2nd of 30 the highest of 30 other Stage II Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stage II Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.
RECRUITING · NA
-
TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
RECRUITING · NA
-
Improving Exercise Capacity With a Tailored Physical Activity Intervention
RECRUITING · NA
-
A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)
ACTIVE NOT RECRUITING · NA
-
Researching the Effect of Exercise on Cancer
ACTIVE NOT RECRUITING · NA
-
Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04510129 · 1,650 participants
A Multicenter Cancer Biospecimen Collection Study
- NCT05612750 · 1,650 participants · NA
Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study
- NCT06215716 · 1,650 participants · Phase 3
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
- NCT07046260 · 1,650 participants
Prospective Study to Assess a Diagnostic Aid for Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia